Safety and Stability of Pulmonary Function in Patients with Decreased Respiratory Function Treated for Spasticity with OnabotulinumtoxinA

Two randomized, placebo-controlled studies evaluated the pulmonary function safety of onabotulinumtoxinA (onabotA) for treatment of upper and/or lower limb spasticity. Patients with stable baseline respiratory status received one or two treatments with placebo, 240 U, or 360 U of onabotA. Pulmonary...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayyoub, Ziyad, Brashear, Allison, Banach, Marta, Schoene, Robert, Stringer, William, Boodhoo, Terry, Yushmanova, Irina, Dimitrova, Rozalina, Brin, Mitchell F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589715/
https://www.ncbi.nlm.nih.gov/pubmed/33086749
http://dx.doi.org/10.3390/toxins12100661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589715/
https://www.ncbi.nlm.nih.gov/pubmed/33086749
http://dx.doi.org/10.3390/toxins12100661

Ejemplares similares